Continuing Education for Healthcare Professionals
International College of Human Nutrition and Functional Medicine ICHNFM.ORG
ICHNFM Logo
Human Microbiome and Dysbiosis in Clinical Disease
The clinicians’ guide to the understanding, assessment, and pharmacologic and nonpharmacologic treatment of microbiome imbalances and the metabolic inflammatory consequences Human Microbiome and Dysbiosis in Clinical Disease.
FCM Joint Providership Services
Within the framework of the ACCME requirements, there are opportunities for ACCME accredited providers like FCM to plan and implement CME activities with organizations that are not accredited by the ACCME. This approach refers to ‘joint providership’ and accounts for a sizable portion of the CME conducted annually by ACCME accredited providers.
FEATURED Online Courses
Anticoagulation Reversal: Case 1 - Sensible Risk Stratification
Presented by: Peter J. Kudenchuk, MD Credits: .5 Learn More

This interactive case study discussion will provide the knowledge and tools to enable the primary care provider to use scoring systems such as the CHADS-VASc,and HAS-BLED to stratify patients risk potential for bleeding due to anticoagulation therapy.

Case: A 40-year old male from the Xinjiang Province in China presents with ischemic stroke, category 4 on the LAMS (Los Angeles Motor Scale). He is a crewmember on a Chinese freighter offloading in a U. S. port city when he collapses and is rushed to a local hospital. The captain has no information on the crewmember’s medical history but notes that the patient is a heavy smoker and tends to binge drink when portside.

Outcome Objectives:

  • Utilize scoring systems (CHADS-VASc, HAS-BLED) to risk-stratify patients considered for anticoagulation therapies and mitigate their bleeding risk

Funded through an educational grant from Portola Pharmaceuticals Inc.

To continue select your profession.

 
Anticoagulation Reversal: Case 2 - Converting Between Anticoagulants
Presented by: Peter J. Kudenchuk, MD Credits: .5 Learn More

This interactive case study discussion will provide the knowledge and tools to enable the primary care provider to explain the incidence and sources of bleeding related to the use of oral anticoagulants and its impact on health care; compare the difference in bleeding risk between oral vitamin K antagonists and direct oral anticoagulants (DOACs) and be able to convert from one anticoagulant to another.

Case: A 57-year old Alaska Native female has been taking Warfarin for several years for non-valvular AF and wishes to switch to one of the newer DOACs, which she hears are safer.

Outcome Objectives:

  • Explain the incidence and sources of bleeding related to the use of oral anticoagulants and its impact on health care.
  • Compare the difference in bleeding risk between oral vitamin K antagonists and direct oral anticoagulants (DOACs).
  • Describe a strategy for conversion from one anticoagulant to another

Funded through an educational grant from Portola Pharmaceuticals Inc.

To continue select your profession.

 
Anticoagulation Reversal: Case 3 - Reversing Anticoagulation
Presented by: Peter J. Kudenchuk, MD Credits: .5 Learn More

This interactive case study discussion will provide the knowledge and tools to enable the primary care provider to understand the mechanism of anticoagulation and its reversal for oral vitamin K anticoagulants and the DOAC agents.

Case: An 82 year old male suffers a subdural hematoma after falling down a flight of concrete stairs. He is taking Warfarin. Past history remarkable for controlled HTN and diet-managed type 2 DM.

Outcome Objectives:

  • Characterize the mechanism of anticoagulation and its reversal for oral vitamin K anticoagulants and the DOAC agents

Funded through an educational grant from Portola Pharmaceuticals Inc.

To continue select your profession.

 
Anticoagulation Reversal: Case 4 - Stopping the Bleed - A 4 Step Approach
Presented by: Peter J. Kudenchuk, MD Credits: .5 Learn More

This interactive case study discussion will provide the knowledge and tools to enable the primary care provider to understand the efficacy and limitations of current approaches to reversing anticoagulation in recipients of oral vitamin K antagonists and the mechanisms of the current reversal agents for DOACs and how they differ from approaches for reversal of vitamin K antagonists.

Case: A 59-year old male suffers a major GI bleed. He has been taking dabigatran for the past year for nonvalvular AF.

Outcome Objectives:

  • Describe the efficacy and limitations of current approaches to reversing anticoagulation in recipients of oral vitamin K antagonists
  • Characterize the mechanisms of the current reversal agents for DOACs and how they differ from approaches for reversal of vitamin K antagonists. 

Funded through an educational grant from Portola Pharmaceuticals Inc.

To continue select your profession.

 
Plant-Based Nutrition: Research and Application in the Medical Practice
Presented by: Thomas M. Campbell, MD Credits: 5 Learn More

A 2010 study found that, among cardiac patients, perceived low-quality of care was associated with not receiving diet and lifestyle advice. Simultaneously, there seems to be a growing awareness that common chronic diseases are profoundly linked to diet and lifestyle practices. In particular, plant-based diets have become more popular. Variations of plant-based diets are espoused by the past-president of the American College of Cardiology, the American College of Lifestyle Medicine, the American Institute for Cancer Research, and a variety of new diet and lifestyle programs in medical institutions and lay public communities. The scientific advisory panel for the US dietary guidelines committee advised more plant-based diets, and the US Preventive Services Task Force recommends that all overweight and obese patients with heart disease risk factors be referred to intensive behavioral interventions.

Topics covered include:

  1. Defining Plant-Based Nutrition and its Broad Benefits
  2. Plant-Based Nutrition and Ischemic Heart Disease
  3. Plant-Based Nutrition and Diabetes
  4. Challenges to Behavior Change and Food Addiction
  5. Counseling Patients to Change: Better Addressing Barriers
  6. Setting up Diet and Lifestyle Programs in Medicine

This 6-module course was developed at the T. Colin Campbell Center for Nutrition Studies, which offers a renowned certificate program in plant-based nutrition in partnership with eCornell, Cornell University’s online course provider.

To continue select your profession.

 
Case Studies In Heart Failure
Presented by: Peter J. Kudenchuk, MD, Nicholas D. Wyatt, PharmD Credits: 2.5 Learn More

Heart failure impacts the lives of thousands upon thousands of patients as well as their family members every year. The disease cost the healthcare system billions of dollars every year and is expected to continue to rise.

This course will give the participant the resources and tools necessary to become a heart failure expert. Our discussion will start with the epidemiology of heart failure. Then we will transition into discussing the stages of heart failure, specifically focusing on the four stages of heart failure and the evidence treatments of these four stages. Thanking you for joining me on your journey to becoming a heart failure expert. Let' get started.

Outcome Objective
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Describe the clinical epidemiology of heart failure and its impact on health care delivery and costs.
  2. List the modifiable risk factors of heart failure
  3. Identify the non-modifiable risk factors of heart failure
  4. Describe the population attribution risk of heart failure for modifiable and non-modifiable risk factors
  5. Define the four stages of the ACC/AHA heart failure staging model.
  6. Describe the four classification stages of the NYHA heart failure staging model.
  7. Describe the neurohormonal response in patients with and without heart failure.
  8. Identify key compensatory neurohormones in heart failure patients.
  9. Describe the renin-angiotension system response in patients with heart failure.
  10. List the compensatory responses that maintain circulation as a result of decreased cardiac output.
  11. Name two biomarkers used in the diagnosis and assessment heart failure.
  12. Discuss the four components of examining the heart failure patient.

To participate in this activity you must be Registered and Logged In to this website.

ABIM MOC LogoSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.

To continue select your profession.

 

About FCM

Resource Downloads

Links